Akorn, Inc. Announces First Quarter 2013 Earnings Release And Conference Call Information

Wed Apr 3, 2013 4:00pm EDT

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130403:nPnCL88267


LAKE FOREST, Ill.,  April 3, 2013  /PRNewswire/ -- Akorn, Inc. (NASDAQ: AKRX)
will host a conference call on Tuesday, May 7, 2013, to discuss first quarter
2013 results followed by a Q&A session.  The company will release earnings the
same day before the market opens.

 Subject:                Akorn, Inc. First Quarter 2013 Conference Call    
 Date/Time:              Tuesday, May 7, 2013, at 10:00 a.m. Eastern Time  
 Domestic Callers:       888-539-3678                                      
 International Callers:  719-325-2455                                      
 Confirmation Code:      3749013                                           
 URL For Webcast:        http://www.videonewswire.com/event.asp?id=93244   


http://www.videonewswire.com/event.asp?id=93244

A live broadcast of Akorn's conference call will also be available online at 
www.akorn.com  under the Investor Relations tab on  May 7, 2013, beginning at 
10:00 a.m. (Eastern Time).  The online replay will follow immediately and will
be available for 30 days.   

About Akorn, Inc.

Akorn, Inc. is a niche pharmaceutical company engaged in the development,
manufacture and marketing of multisource and branded pharmaceuticals.  Akorn has
manufacturing facilities located in  Decatur, Illinois;  Somerset, New Jersey 
and Paonta Sahib,  India  where the Company manufactures sterile ophthalmic and
injectable pharmaceuticals.  Additional information is available on the
Company's website at  www.akorn.com.  

SOURCE  Akorn, Inc.


Tim Dick, Chief Financial Officer, (847) 279-6150

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.